## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.8% in lower entry zone (4.0-10.0%), top quartile (85th pct) cross-sectional ranking. Short-term MRS_5 (3.9%) confirms momentum alignment. Strong momentum (+8.5% 5-day acceleration). Outperforming sector by 4.1%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($61.18)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Assessing Eastman Chemical’s Valuation After Its 16th Straight Dividend Hike and New Cost-Cutting Goals**
- Source: Simply Wall Street | 20251213T180751 | Somewhat-Bullish | Relevance: 100%
- Eastman Chemical (EMN) has increased its dividend for the 16th consecutive year and announced new cost-cutting goals. Despite negative share price momentum over the past year, a recent rebound suggests stabilizing sentiment. The stock is currently trading at a discount to analyst targets, prompting a valuation debate regarding whether it presents a buying opportunity.

**2. Assessing Eastman Chemical’s Valuation After Its 16th Straight Dividend Hike and New Cost-Cutting Goals**
- Source: Simply Wall Street | 20251213T180745 | Somewhat-Bullish | Relevance: 100%
- Eastman Chemical (EMN) has increased its dividend for the 16th consecutive year and announced new cost-cutting goals. Despite negative shareholder returns over the past year, a recent rebound suggests stabilizing sentiment. The stock appears undervalued at $65.12 against a fair value of $72.76, prompting investors to consider if this represents a buying opportunity.

**3. Are Wall Street Analysts Predicting Eastman Chemical Stock Will Climb or Sink?**
- Source: MSN | 20251212T220746 | Neutral | Relevance: 100%
- This article examines Wall Street analyst predictions for Eastman Chemical (EMN), focusing on whether they anticipate a stock price increase or decrease. It delves into the factors influencing these forecasts, providing insights into the potential future performance of EMN based on expert opinions.

**4. We Wouldn't Be Too Quick To Buy Eastman Chemical Company (NYSE:EMN) Before It Goes Ex-Dividend**
- Source: Simply Wall Street | 20251210T110826 | Somewhat-Bearish | Relevance: 100%
- Eastman Chemical Company (NYSE:EMN) is about to pay a dividend, but the article advises caution before buying for this reason. The company's dividend payout is 55% of profits but 96% of free cash flow, raising concerns about sustainability. While earnings per share have grown modestly, the dividend's coverage by cash flow is a red flag for potential investors.

**5. We Wouldn't Be Too Quick To Buy Eastman Chemical Company (NYSE:EMN) Before It Goes Ex-Dividend**
- Source: Simply Wall Street | 20251210T110815 | Bearish | Relevance: 100%
- Eastman Chemical Company (NYSE:EMN) is approaching its ex-dividend date of December 15th, with a dividend payment of US$0.84 per share. While the company's earnings have seen modest growth, its dividend payout ratio is 55% of profit, and it paid out 96% of its free cash flow in dividends last year, raising concerns about sustainability and cash flow coverage. Investors should consider these factors and potential risks despite the steady dividend growth over the past decade.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.08M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Valuation risk: PEG 3.9x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 10.5% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +8.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.87 signals overvaluation risk, limited margin of safety. Forward P/E 10.4x attractive for 15% earnings growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.5B |
| Beta | 1.25 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.87 |
| Forward P/E | 10.4 |
| Current P/E | 11.9 |
| YoY Growth | 14.6% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -1.7% to 6.8% (+8.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 85th percentile. MRS_5 at 3.9% confirms short-term momentum alignment. AM_20 at 7.2% shows strong absolute momentum above own 20MA. Outperforming sector by 4.1pp, stock-specific strength. Below SMA200 (0.90x), long-term trend not supportive. MACD histogram positive (0.64), confirming momentum. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.79% (CS: 85) | Strong |
| RSI_14 | 61.5 | Neutral |
| MACD Histogram | 0.64 | Bullish |
| vs SMA20 | 1.071x | Above |
| vs SMA50 | 1.066x | Above |
| vs SMA200 | 0.895x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $65.12
- **Stop Loss:** $61.18 (6.1% risk)
- **Target:** $71.03 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 304
- **Position Value:** $19,796.48
- **Portfolio %:** 19.80%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*